Mezym (Pancreas Powder)

Pancreas Powder contains a blend of lipase, amylase, and protease enzymes that mimic the natural pancreatic secretions. When taken orally, the enzymes become active in the small intestine, where they hydrolyze dietary fats, carbohydrates, and proteins, facilitating their absorption and improving nutritional status.

The dose of Mezym is individualized and determined by the prescribing healthcare professional based on the patient’s age, weight, severity of pancreatic insufficiency, and dietary fat intake. Patients should follow the prescriber’s instructions and adjust the dose only under medical supervision.

Safety data for Mezym in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks before recommending use in pregnant or nursing individuals. If prescribed, it should be used only when clearly needed.

To order Mezym, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mezym provides a broad spectrum of pancreatic enzymes similar to other enzyme replacement therapies such as Creon or Pancreaze. Differences may lie in enzyme activity units, formulation (powder vs. capsule), and manufacturing origin. Clinicians choose a product based on patient tolerance, dosing flexibility, and cost considerations.

Mezym should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight. Do not store in the refrigerator or freezer unless specifically instructed by the manufacturer.

Mezym is taken orally, usually with meals or snacks that contain fat, to ensure the enzymes mix with ingested food in the gastrointestinal tract. The tablets or powder should be swallowed whole with a sufficient amount of water, following the dosing schedule prescribed by the healthcare provider.

Serious risks include allergic reactions such as rash, swelling, or anaphylaxis, and rare events like severe abdominal pain indicating pancreatitis or intestinal obstruction. Patients should seek immediate medical attention if they experience any signs of a severe reaction or unexplained gastrointestinal distress.

Mezym should not be used by individuals with a known hypersensitivity to porcine or bovine pancreatic extracts or any other component of the formulation. It is also contraindicated in patients with active gastrointestinal obstruction or severe inflammatory bowel disease until the condition is resolved.